Allosteric Proteins-ATCase
Phosphoinositides and PIPs
Riboswitches
Targets for Drug Action: Overview
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
GPCR Desensitization
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 16, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Anika J Friedman1, Hannah M Padgette1, Levi Kramer1
1Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado 80309, United States.
Minor differences in protein structure enable selective inhibition of protein tyrosine phosphatases (PTPs), crucial drug targets for diseases like cancer. This selectivity can be enhanced through chemical modifications of inhibitors.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: